Transnetyx, Inc.

Memphis, TN Doing business as Transnetyx Inc.

UEI
CNG6DGADGL38
CAGE
4QEG3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
8110 Cordova Rd #119, Cordova, TN 38016, USA
Website
transnetyx.com
Founded
2000
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Transnetyx, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Niams:service: genotyping services of rodent samples: non-severable Contract · 75N98026P01157 Office of Logisitics and Acquisition Operations $176,712
Nibib - genotyping Contract · 75N98026F00005 Office of Logisitics and Acquisition Operations $20,000
Service: mouse genotyping services, reference quote no. TYXML2026104GT. Contract · 75N98026P00880 Office of Logisitics and Acquisition Operations $40,000
Automated genotyping Contract · 36C24E26N0069 Veterans Integrated Service Network 4 $75,000
Genotyping Contract · 36C24E26N0102 Veterans Integrated Service Network 4 $5,322

About Transnetyx, Inc.

Transnetyx, Inc., headquartered in Cordova, Tennessee, is a for-profit genetic testing and bioinformatics firm that delivers automated genotyping, DNA extraction, multi-gene analysis, and genetic monitoring services to federal research agencies as a prime contractor, competing in the open market with no set-aside designations across its footprint.

Transnetyx operates entirely as a prime contractor—all 275 awards in the source data are prime positions—and serves the federal research ecosystem with a focused capability set: laboratory-based genetic analysis for transgenic rodents (mice and rats) supporting biomedical research. Core services include real-time PCR genotyping with 72-hour or faster turnaround, DNA extraction, multi-gene assay design and processing, bioinformatics database hosting and XML integration with agency colony-management systems (notably the NIH Progeny Database and Softmouse), and genetic monitoring for breeding colony maintenance and experimental cohort designation. The company maintains performance facilities in Cordova, Tennessee (primary operations), with satellite locations in Baltimore, Maryland; Bethesda and North Bethesda, Maryland; and Portland, Oregon. Concrete representative work includes a $1.2 million delivery order from the National Institute of Environmental Health Sciences (NIEHS) for animal genotyping services running September 2024 through September 2025 under a $7 million indefinite delivery vehicle; a $1.08 million delivery order from NIEHS for FY26 genotyping services; a $1.1 million delivery order from NIEHS (Clayton, Alabama location) for FY2022–2023 animal genotyping; and a $366 thousand delivery order from the National Institute on Aging (NIA) for the NIA Genotyping Outsourcing Project supporting colony management and research sample processing.

Customer concentration is pronounced and skews to environmental health and neurological research. The National Institute of Environmental Health Sciences dominates both potential value (36 awards, $28.8 million combined potential value) and serves as an anchor customer through large multi-year indefinite delivery vehicles. The Office of Logistics and Acquisition Operations (NIH's centralized procurement office) ranks second by dollars (11 awards, $11.9 million) through a $10 million blanket purchase agreement for laboratory and testing supplies—a vehicle Transnetyx uses to aggregate task orders from distributed NIH institutes. The National Institute on Aging (13 awards, $6.2 million) is a third major customer, tied to the NIA Genotyping Outsourcing Project. The National Institute on Drug Abuse (75 awards, $1.1 million) leads by order count but represents lower per-order magnitude. Together, these five customers account for 93% of combined potential value. A tension exists between volume and value: NIDA places the most individual orders but anchors relatively low potential value per order, while NIEHS and OLA place fewer but substantially larger orders.

Transnetyx holds parent vehicles across NIH institutes structured as blanket purchase agreements and indefinite delivery contracts. The single-award $10 million BPA with the Office of Logistics and Acquisition Operations (awarded October 2024, completion October 2026) serves as a hub vehicle distributing task orders to NINDS, NIAAA, NHGRI, NCCIH, and NHLBI; 130 task orders have been issued against it. A $7 million IDC with NIEHS (awarded September 2021, completion September 2026) anchors large-dollar delivery orders for animal genotyping supporting environmental health research. A $1.696 million IDC with NIA (awarded April 2026, completion April 2031) provides base-year and four renewal options for the Genotyping Outsourcing Project, with deliverables including PCR analysis for one to ten genes per sample, 72-hour processing, weekly quality assurance, and XML integration with the NIA Progeny Database. Additional smaller vehicles include a $375 thousand single-award IDC with Veterans Integrated Service Network 21 (awarded June 2025, completion June 2030) and a $11,143 IDC with Veterans Integrated Service Network 4 (awarded April 2026, completion April 2028). Transnetyx also holds Blanket Purchase Agreements with the National Institute of Biomedical Imaging and Bioengineering (completion February 2027), NINDS, and scattered smaller awards from NIAID, NHLBI, NCCIH, NEI, NHGRI, and NIMH.

Activity has grown from 4 awards in 2022 to a peak of 35 in 2024, with 31 awards in 2025 and 8 year-to-date in 2026. Nineteen awards with combined potential value of $3.4 million face ultimate completion within the next twenty-four months, representing moderate recompete exposure. The company operates with no subcontractors across the prime portfolio—0% of awards are sub-awards—and does not report sub-engagement across SCI-reportable contracts, indicating in-house service delivery model.

Service Contract Inventory data captures a narrow slice: $1.2 million in invoiced revenue across three SCI-reportable prime contracts in FY2022, with zero SCI invoicing in FY2023–2024 and a total of 13 SCI records (12 prime, 1 sub). The FY2022 data report 2,861 contract-level FTEs, but this figure reflects the labor-hours allocation method used by SCI rather than headcount; subsequent fiscal years show minimal SCI-reportable labor (8.0 FTEs in FY2024, 0.0 in FY2023), indicating that most Transnetyx federal service work operates below the $150,000 SCI reporting threshold or falls outside SCI scope (goods, materials, tools). Government-paid hourly rates derived from SCI invoicing are flat at $0.21/hr across the 10th, median, and 90th percentiles—a unit-rate artifact reflecting per-sample pricing (genotyping by the sample) rather than hourly labor billing. The SCI picture is incomplete; the award portfolio shows $52.4 million in combined potential value against $20.6 million obligated (39%), indicating substantial federal services activity not captured in SCI due to contract structure and size.

Transnetyx operates through a parent holding structure with three named subsidiaries: Laragen Holdco LLC (self-certified small disadvantaged business, limited liability company), Brainbits LLC (manufacturer of goods, limited liability company), and A-Tune Software Inc. (for-profit organization). The parent entity holds no SBA certifications in the source data; the company competes full-and-open across all recent awards without set-asides or small-business designations, positioning itself as a market-rate vendor in NIH and VA genotyping procurement.

Quick answers

What is Transnetyx, Inc.'s UEI?

Transnetyx, Inc.'s Unique Entity ID (UEI) in SAM.gov is CNG6DGADGL38.

What is Transnetyx, Inc.'s CAGE code?

Transnetyx, Inc.'s CAGE code is 4QEG3.

What is Transnetyx, Inc.'s primary NAICS code?

Transnetyx, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Transnetyx, Inc. located?

Transnetyx, Inc.'s physical address in SAM.gov is 8110 Cordova Rd #119, Cordova, TN 38016, USA.

Is Transnetyx, Inc. registered in SAM.gov?

Yes. Transnetyx, Inc.'s SAM.gov registration is active through September 24, 2027.

What is Transnetyx, Inc.'s most recent federal award?

Transnetyx, Inc.'s most recent federal contract award is Niams:service: genotyping services of rodent samples: non-severable (75N98026P01157), from Office of Logisitics and Acquisition Operations, on August 17, 2026.

On GovTribe

See Transnetyx, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors